Sunday, 29 March 2020

World News

  • P&G to acquire Merck KGaA consumer health unit

    World |  News | 0 Comment | 19 Apr, 2018

    Singapore- Procter & Gamble has confirmed that it has signed a deal to acquire the Consumer Health business of Merck KGaA for €3.4 billion -- about $4.21 billion, one of the c...Read more

  • New commercial chief at Ra Pharma

    World |  News | 0 Comment | 19 Apr, 2018

    Singapore- Ra Pharmaceuticals, a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for the treatment of complement-mediated diseases, anno...Read more

  • J&J ramps up pricing for Imbruvica

    World |  News | 0 Comment | 19 Apr, 2018

    Singapore- Johnson & Johnson will implement a new pricing and dosage scheme for cancer med IMBRUVICA (ibrutinib) conveniently ahead of research that suggests the drug, which costs ~$148...Read more

  • Mundipharma expands partnership with Caris Life Sciences

    World |  News | 0 Comment | 18 Apr, 2018

    Mundipharma is partnering with Caris Life Sciences, a leading US biotechnology company, to provide the exclusive sales, promotion, marketing and distribution of its tumor profiling service,...Read more

  • Novartis to invest $100M for malaria elimination

    World |  News | 0 Comment | 18 Apr, 2018

    Novartis has announced a five-year commitment to the fight against malaria in conjunction with the 7th Multilateral Initiative on Malaria Conference and the Malaria Summit of the Commonweal...Read more

  • Sartorius Stedim Biotech, PSU announce partnership

    World |  News | 0 Comment | 18 Apr, 2018

    Sartorius Stedim Biotech and Penn State University (PSU) have entered into a collaborative partnership to advance multidisciplinary teaching and research in biotechnology. This long-term re...Read more

  • GE launches new facility for viral vector based therapeutics

    World |  News | 0 Comment | 17 Apr, 2018

    GE Healthcare is launching a ready-to-run factory-in-a-box to speed up the production of viral vector based therapeutics, including viral vector based vaccines, oncolytic viruses and gene a...Read more

  • Shire offloads its oncology business for $2.4B

    World |  News | 0 Comment | 17 Apr, 2018

    Shire, a leading global biotechnology company focused on rare diseases is selling its oncology business to French drugmaker Servier S.A.S. for $2.4 billion. The US-based company said that t...Read more

  • Maternal metabolic factors and early-onset puberty may be related

    World |  News | 0 Comment | 16 Apr, 2018

    Singapore - In a study of more than 15,000 girls and their mothers — all Kaiser Permanente members in Northern California — maternal overweight and hyperglycemia were ...Read more

  • Major Italian sector federations showcase latest trends in healthcare

    World |  News | 0 Comment | 16 Apr, 2018

    Singapore – Nine major Italian federations representing sectors from fashion to healthcare and technology, arrived in Singapore to promote the “Made In Italy” label. ...Read more

  • UK team develops novel skin patch for diabetes

    World |  News | 0 Comment | 13 Apr, 2018

    A group of scientists at the University of Bath has created a non-invasive adhesive patch that promises the measurement of glucose levels through the skin without carrying out the pain...Read more

  • Merck to accelerate global access to affordable vaccines

    World |  News | 0 Comment | 13 Apr, 2018

    Merck, a leading science and technology company has announced a partnership with Oxford University’s Jenner Institute to develop more robust and scalable vaccine manufacturi...Read more

  • Sanofi to invest in Canadian vaccine facility

    World |  News | 0 Comment | 13 Apr, 2018

    Singapore- Sanofi is investing €350M (CAD $500M) to construct a new state-of-art vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters in Toronto, Ontario. Th...Read more

  • Mylan, Biocon to launch Adalimumab Biosimilar in EU

    World |  News | 0 Comment | 13 Apr, 2018

    Mylan and Biocon have agreed to accelerate introduction of adalimumab biosimilar in Europe through Mylan’s in-licensing arrangement with Fujifilm Kyowa Kirin Biologics (FKB).  F...Read more

  • Boston Therapeutics poised to acquire MTA

    World |  News | 0 Comment | 13 Apr, 2018

    Singapore- Boston Therapeutics inks a non-binding letter of intent with Medical Technology Associates to acquire MTA, a privately-held company dedicated to the development of nove...Read more

  • Abpro Therapeutics on deck for IPO

    World |  News | 0 Comment | 13 Apr, 2018

    Singapore- Woburn, MA-based Abpro Therapeutics (ABP) has filed a preliminary prospectus for a $69M IPO. The preclinical-stage biotech firm develops next-generation anti...Read more

  • Capital raise for Vermillion

    World |  News | 0 Comment | 13 Apr, 2018

    Singapore- Vermillion, a bio-analytical solutions company focused on gynecologic disease, announced that it intends to offer shares of its common stock and convertible preferred stock in co...Read more

  • New study brings relief for travellers from leg swelling and jet lag

    World |  News | 0 Comment | 13 Apr, 2018

    Singapore- A new peer-reviewed, published study shows that natural French maritime pine bark extract Pycnogenol is effective in reducing lower leg swelling known as edema and relieving jet ...Read more



Podcast

 

Survey Box

Are women in the industry getting the required recognition for their efforts?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls